Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/35064
Title: A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci
Author: Pillai, Sreekumar G.
Ge, Dongliang
Zhu, Guohua
Kong, Xiangyang.
Shianna, Kevin V.
Need, Anna C.
Feng, Sheng
Hersh, Craig P.
Bakke, Per
Gulsvick, , Amund
Ruppert, Andreas
Lødrup, Karin C.
Roses, Allen
Anderson, Wayne
Agustí García-Navarro, Àlvar
Rennard, Stephen I.
Lomas, David A
Silverman, Edwin K.
Goldstein, David B.
Keywords: Malalties pulmonars obstructives cròniques
Genòmica
Càncer de pulmó
Chronic obstructive pulmonary diseases
Genomics
Lung cancer
Issue Date: 20-Mar-2009
Publisher: Public Library of Science (PLoS)
Abstract: There is considerable variability in the susceptibility of smokers to develop chronic obstructive pulmonary disease (COPD). The only known genetic risk factor is severe deficiency of alpha(1)-antitrypsin, which is present in 1-2% of individuals with COPD. We conducted a genome-wide association study (GWAS) in a homogenous case-control cohort from Bergen, Norway (823 COPD cases and 810 smoking controls) and evaluated the top 100 single nucleotide polymorphisms (SNPs) in the family-based International COPD Genetics Network (ICGN; 1891 Caucasian individuals from 606 pedigrees) study. The polymorphisms that showed replication were further evaluated in 389 subjects from the US National Emphysema Treatment Trial (NETT) and 472 controls from the Normative Aging Study (NAS) and then in a fourth cohort of 949 individuals from 127 extended pedigrees from the Boston Early-Onset COPD population. Logistic regression models with adjustments of covariates were used to analyze the case-control populations. Family-based association analyses were conducted for a diagnosis of COPD and lung function in the family populations. Two SNPs at the alpha-nicotinic acetylcholine receptor (CHRNA 3/5) locus were identified in the genome-wide association study. They showed unambiguous replication in the ICGN family-based analysis and in the NETT case-control analysis with combined p-values of 1.48 x 10(-10), (rs8034191) and 5.74 x 10(-10) (rs1051730). Furthermore, these SNPs were significantly associated with lung function in both the ICGN and Boston Early-Onset COPD populations. The C allele of the rs8034191 SNP was estimated to have a population attributable risk for COPD of 12.2%. The association of hedgehog interacting protein (HHIP) locus on chromosome 4 was also consistently replicated, but did not reach genome-wide significance levels. Genome-wide significant association of the HHIP locus with lung function was identified in the Framingham Heart study (Wilk et al., companion article in this issue of PLoS Genetics; doi:10.1371/journal.pgen.1000429). The CHRNA 3/5 and the HHIP loci make a significant contribution to the risk of COPD. CHRNA3/5 is the same locus that has been implicated in the risk of lung cancer.
Note: Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pgen.1000421
It is part of: PLoS Genetics, 2009, vol. 5, num. 3, p. 1-8
Related resource: http://dx.doi.org/10.1371/journal.pgen.1000421
URI: http://hdl.handle.net/2445/35064
ISSN: 1553-7390
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
609835.pdf228.1 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons